In personalized medicine, methylation biomarkers enable tailored treatment plans based on an individual's specific methylation profile. For example, in colorectal cancer, the detection of methylation in the SEPT9 gene can guide the choice of therapeutic strategies. This approach ensures that patients receive the most effective treatments with minimal side effects.
